statistiche ricercatore

statistiche per SENNI, MICHELE

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1605
EU - Europa 305
AS - Asia 105
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1574
IT - Italia 137
SE - Svezia 74
CN - Cina 48
VN - Vietnam 32
CA - Canada 31
UA - Ucraina 27
DE - Germania 12
RO - Romania 11
DK - Danimarca 10
FR - Francia 8
IR - Iran 8
NL - Olanda 7
GB - Regno Unito 6
IN - India 6
JP - Giappone 5
RU - Federazione Russa 5
TN - Tunisia 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
NO - Norvegia 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
ES - Italia 1
IE - Irlanda 1
MD - Moldavia 1
PL - Polonia 1
QA - Qatar 1
RS - Serbia 1
Totale 2025
Salva come PNG Salva come JPEG
Città #
Ann Arbor 529
Fairfield 274
Wilmington 123
Woodbridge 97
San Diego 92
Ashburn 83
Cambridge 82
Houston 79
Seattle 69
San Mateo 33
Dong Ket 28
Toronto 23
Dearborn 22
Milan 20
Fremont 12
Nanjing 12
Laurel 8
Rome 8
Jacksonville 7
Andover 6
Guangzhou 6
Norwalk 6
San Giuliano Milanese 6
Tabriz 6
Alexandria 5
Boardman 5
Genzano Di Roma 5
Tianjin 5
Hunedoara 4
Jinan 4
Sacramento 4
Bucharest 3
Duncan 3
Hangzhou 3
Jiaxing 3
Kocaeli 3
Menlo Park 3
Montréal 3
Ottawa 3
Shenyang 3
Changsha 2
Dallas 2
Deventer 2
Garden City 2
Kiev 2
Krimpen Aan Den Ijssel 2
Lainate 2
Nanchang 2
Oslo 2
Pescara 2
Redmond 2
Scordia 2
Treviglio 2
Trumbull 2
Zhengzhou 2
Adana 1
Agrate Brianza 1
Beijing 1
Bergamo 1
Brescia 1
Chisinau 1
Clearwater 1
Covo 1
Cupertino 1
Doha 1
Dublin 1
Edmonton 1
Gandino 1
Halle 1
Hebei 1
Hefei 1
Kunming 1
Leawood 1
Lecce 1
Madrid 1
Mahé 1
Mumbai 1
Nettuno 1
Ningbo 1
Padova 1
Pavullo Nel Frignano 1
Phoenix 1
Raleigh 1
Reghin 1
Saronno 1
Viareggio 1
Winnipeg 1
Totale 1752
Salva come PNG Salva come JPEG
Nome #
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 268
Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis multicenter Lombardy registry 182
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 148
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 101
Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study 100
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 90
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 87
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 83
The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique 77
Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study 76
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study 73
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction 68
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 60
QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance 44
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure 39
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 38
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 36
An unusual case of cardiac aspergillosis 31
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 25
Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion [Grey zones sull'uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinioni degli esperti] 20
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 20
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 19
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysis 17
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry 15
Reasons why patients suffering from chronic heart failure at very low risk for mortality die 12
Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence? 12
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient's Journey with Heart Failure and Reduced Ejection Fraction 12
Is 3D Echo With Ramp Test Indicated in Detecting Blood Flow Obstructions in HeartWare LVAD? 11
Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol 11
Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction 11
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study 11
Erratum: Heart failure at the crossroads: Moving beyond blaming stakeholders to targeting the heart (Eur J Heart Fail (2015) 17:8 (760-763) doi:10.1002/ejhf.315)) 11
Heart rate and outcome in patients with acute and chronic heart failure [La frequenza cardiaca e la prognosi nello scompenso cardiaco acuto e cronico] 10
Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients 10
Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: The relevance of the left ventricular equator as a prognostic factor 9
Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation 9
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens 9
Cardiac Resynchronization in Combination with beta-blocker treatment in advances heart failure (CARIBE-HF): study design and preliminary results of pilot phase 9
Addressing the Heterogeneity of Heart Failure in Future Randomized Trials 9
Effect of changes in flow on the determination of orifice area in the mitral position by pressure half-time 9
Remote Monitoring of Respiratory Pattern in an ICD Patient With COVID-19 Pneumonia 9
Evolocumab and clinical outcomes in patients with cardiovascular disease 9
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 9
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides 8
Prognostic scores in heart failure - Critical appraisal and practical use 8
Hemodynamic arterial changes in heart failure: a proposed new paradigm of "Heart and Vessels Failure (HVF)" 8
Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: Data from a large nationwide cardiology database (IN-CHF registry) 8
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study 8
Heart failure with preserved ejection fraction: Update on diagnosis and therapy [Scompenso cardiaco con frazione di eiezione preservata: Update in tema di diagnosi e terapia] 8
Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations 7
Epidemiologic and clinical profiles of bacterial myocarditis. Report of two cases and data from a pooled analysis 7
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy 7
Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials 7
Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart 7
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 7
Heart failure with preserved ejection fraction in Asia: the far side of the moon? 7
Cavotricuspid isthmus ablation and subcutaneous monitoring device implantation in a 2-year-old baby with 2 scn5a mutations, sinus node dysfunction, Atrial flutter recurrences, and drug induced long-qt syndrome: A tricky case of pediatric overlap syndrome? 7
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure 7
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology 7
An Intriguing Case Report of Functional Mitral Regurgitation Treated With MitraClip 7
Assistenza ventricolare sinistra dopo correzione combinata di stenosi valvolare aortica e coartazione istmica 7
Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives 7
Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation 7
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure 7
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF 7
A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure 7
Cardiogenic shock: How to overcome a clinical dilemma. Unmet needs in Emergency medicine 7
Monitoring of biomarkers in heart failure 7
The Titan can help titin: from micro to macro myocardial elasticity 7
Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study 7
The myosin activator: is another step forward in heart failure therapy? 7
Chirurgia riparativa della mitrale in età pediatrica. Esperienza in 56 casi operati 6
Ruolo dell’ecocardiografia transesofagea nell’indicazione alla terapia chirurgica Delle endocarditi infettive 6
Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion [Grey zones sulla cardiologia interventistica valvolare e cardiochirurgia a confronto. Opinioni degli esperti] 6
A Multidisciplinary Consensus Document on Follow-Up Strategies for Patients Treated With Percutaneous Coronary Intervention 6
Mechanical assisted circulation- comparison between two different anticoagulation protocols- preliminary results in 45 patients 6
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure Insights From the IMAGE-HF Study 6
Effect of a Heart Failure Program on hospitalization rates and morbidity rates 6
Trapianto cardiaco in età pediatrica: esperienza in 34 casi 6
An innovative microemulsion galenic formulation of CyA: pharmacokinetics in long-term and “de novo” heart transplanted patients 6
Plastica Mitralica ed Ecocardiografia Transesofagea nell’Endocardite Acuta in Fase Attiva 6
Early and intermediate term results of Carpentier's repair for Ebstein's anomaly 6
Multivariate analysis of survival in patients in waiting list for heart transplantation 6
Postcardiotomy recovery after repair of congenital defects-comparison of extracorporeal membrane oxygenation with ventricular assist device 6
Critical Heart Rate of Force-Frequency Relationship during Dobutamine Stress Echo predicts outcome in Medically Treated Heart Failure Patients: Echocardiography Doppler 6
Correzione chirurgica con omoinnesti dell’endocardite infettiva aortica 6
Grey zones on dual antiplatelet therapy. Expert opinion 6
Prognosis of patients in waiting list for heart transplantation a multiparametric analysis 6
Diastolic heart failure in the community: A population-based study of incident cases of congestive heart failure in Olmsted County, Minnesota in 1991 6
Characterization of left ventricular systolic and diastolic function by Doppler echocardiography in patients affected by constrictive pericarditis: post- pericardiectomy and serial assessement 6
Importanza dell’ecocardiografia transtoracica e transesofagea nell’assistenza cardiocircolatoria meccanica 6
Trattamento conservativo della valvola mitrale in presenza di endocardite infettiva 6
Ejection fraction of 20% or less is not a contraindication to cardiac surgery 6
Role of TEE and mitral valve repair in the management of heart failure due to acute bacterial endocarditis 6
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction 6
Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing 6
Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis 6
Influence of demographic factors in heart failure: Age, sex and race 6
Good survival of patients considered too-well for heart transplantation 6
Under-utilization of echocardiography in the management of congestive heart failure has adverse effects on morbidity and mortality 6
Totale 2285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201818 0040 00 00 0068
2018/201990 1100 12 94 12152124
2019/2020244 229714 1428 3135 3624195
2020/2021757 35589336 4149 7354 666881103
2021/20222152 79767745 8827 2849 416315790
Totale 3261
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy
Logo CINECA  Copyright © 2022